347 related articles for article (PubMed ID: 11431574)
1. [Metabolism of atherogenic lipoproteins].
Beucler I; Turpin G
Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein metabolism].
Corvilain B
Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
[TBL] [Abstract][Full Text] [Related]
4. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
[TBL] [Abstract][Full Text] [Related]
5. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha.
Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI
Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968
[TBL] [Abstract][Full Text] [Related]
7. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
Braschi S
Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
[TBL] [Abstract][Full Text] [Related]
8. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets.
McCarty MF
Med Hypotheses; 2004; 63(6):1065-73. PubMed ID: 15504577
[TBL] [Abstract][Full Text] [Related]
9. Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen GA
J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
[TBL] [Abstract][Full Text] [Related]
10. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy.
Eisenberg S
Adv Exp Med Biol; 1985; 183():73-84. PubMed ID: 4036705
[No Abstract] [Full Text] [Related]
13. [Lipoprotein lipase (LPL) in the pathogenesis of atherosclerosis].
Skoczyńska A
Postepy Hig Med Dosw; 1998; 52(4):347-65. PubMed ID: 9780756
[TBL] [Abstract][Full Text] [Related]
14. [Insulin-dependent diabetes and lipoprotein metabolism].
Berthezène F; Perrot L; Valentin C; Sautot G
Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
[No Abstract] [Full Text] [Related]
15. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins.
Chung BH; Tallis G; Yalamoori V; Anantharamaiah GM; Segrest JP
Arterioscler Thromb; 1994 Apr; 14(4):622-35. PubMed ID: 8148360
[TBL] [Abstract][Full Text] [Related]
16. [Hypertriglyceridemia: danger for the arteries].
Chanu B
Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
[TBL] [Abstract][Full Text] [Related]
17. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
18. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations.
Bradley WA; Gianturco SH
J Intern Med Suppl; 1994; 736():33-9. PubMed ID: 7986306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
